NAS.L

North Atlantic Smaller Cos Investment Trust Plc
North Atlantic Smlr - Investment Update: Performance Chemicals
3rd October 2024, 10:51
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8585G
North Atlantic Smlr Co Inv Tst PLC
03 October 2024
 

 

https://dw6uz0omxro53.cloudfront.net/2841141/5920af03-1338-4a2f-b876-727a5c8e76e8.gif

North Atlantic Smaller Companies Investment Trust PLC

("NASCIT")

 

 

The Board of the Trust is pleased to announce the sale of Performance Chemicals for approximately £11.6 million.

The company, which is held in the Unquoted Portfolio, had a cost basis of approximately £230,000. The sale is at a modest uplift from the August Dollar valuation and there will be a further uplift of about $1,000,000 should the earn out be achieved and the escrows released as expected.

 

Enquiries:

Christopher Mills and Christopher Hart

020 7640 3200

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUMJBMTMTIMBPI]]>
TwitterFacebookLinkedIn